Class ITerminatedD-0005-2025
Drug recall · October 9, 2024
Veklury recall
Why: Presence of Particulate Matter: Presence of glass particle.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
- Lots / codes
Lot: 47035CFA, Exp. 11/2025
- Quantity
- 105,000 vials
- Company
- Gilead Sciences, Inc., Foster City, CA
- Distribution
- Nationwide in the U.S.A.
- Initiated
- September 19, 2024 · Voluntary: Firm initiated
- Classified
- October 3, 2024
- Reported
- October 9, 2024
- Ended
- July 29, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.